National Medical Care Company (TADAWUL:4005)
Saudi Arabia · Delayed Price · Currency is SAR 119.40
-1.40 (-1.16%)
Sep 3, 2026, 3:16 PM AST
TADAWUL:4005 Ratios and Metrics
Market cap in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,336 | 6,377 | 7,463 | 7,822 | 3,314 | 2,808 | |
Market Cap Growth | -31.38% | -14.55% | -4.58% | 136.00% | 18.05% | 17.23% |
Enterprise Value | 5,892 | 6,429 | 7,514 | 7,213 | 3,266 | 2,550 |
Last Close Price | 119.40 | 138.91 | 160.59 | 165.78 | 69.67 | 58.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.81 | 20.02 | 25.33 | 32.47 | 19.49 | 20.59 |
Forward PE | 16.63 | 17.86 | 23.45 | 29.16 | 20.89 | 19.68 |
PS Ratio | 3.21 | 3.99 | 5.77 | 7.23 | 3.61 | 3.32 |
PB Ratio | 2.86 | 3.45 | 4.59 | 5.38 | 2.62 | 2.50 |
P/TBV Ratio | 3.11 | 3.75 | 5.05 | 5.84 | 2.63 | 2.51 |
P/FCF Ratio | - | 237.96 | 54.62 | 18.95 | 17.84 | 45.57 |
P/OCF Ratio | - | 41.42 | 30.51 | 16.76 | 15.28 | 29.93 |
PEG Ratio | 1.80 | 1.26 | 1.51 | 1.48 | 2.15 | 2.04 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.55 | 4.02 | 5.81 | 6.67 | 3.56 | 3.02 |
EV/EBITDA Ratio | 12.90 | 14.69 | 23.85 | 24.79 | 13.66 | 11.88 |
EV/EBIT Ratio | 17.22 | 18.13 | 29.93 | 29.24 | 16.56 | 15.51 |
EV/FCF Ratio | - | 239.90 | 55.00 | 17.48 | 17.58 | 41.38 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.43 | 0.28 | 0.30 | 0.23 | 0.07 | 0.08 |
Debt / EBITDA Ratio | 1.75 | 1.11 | 1.46 | 1.11 | 0.35 | 0.42 |
Debt / FCF Ratio | - | 19.26 | 3.57 | 0.80 | 0.45 | 1.45 |
Net Debt / Equity Ratio | 0.30 | -0.01 | -0.05 | -0.25 | -0.19 | -0.25 |
Net Debt / EBITDA Ratio | 1.31 | -0.03 | -0.25 | -1.25 | -1.03 | -1.33 |
Net Debt / FCF Ratio | -1.96 | -0.54 | -0.58 | -0.88 | -1.32 | -4.64 |
Asset Turnover | 0.60 | 0.61 | 0.55 | 0.55 | 0.56 | 0.56 |
Inventory Turnover | 14.96 | 16.71 | 15.34 | 14.95 | 14.26 | 13.11 |
Quick Ratio | 4.49 | 3.93 | 3.29 | 3.45 | 3.47 | 3.88 |
Current Ratio | 5.01 | 4.30 | 3.53 | 3.68 | 3.69 | 4.20 |
Return on Equity (ROE) | 16.79% | 18.33% | 19.14% | 17.73% | 14.24% | 12.62% |
Return on Assets (ROA) | 7.68% | 8.41% | 6.66% | 7.85% | 7.54% | 6.87% |
Return on Invested Capital (ROIC) | 13.76% | 19.28% | 19.04% | 21.32% | 18.21% | 17.07% |
Return on Capital Employed (ROCE) | 12.50% | 14.60% | 11.70% | 13.20% | 13.80% | 12.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.61% | 4.99% | 3.95% | 3.08% | 5.13% | 4.86% |
FCF Yield | -5.31% | 0.42% | 1.83% | 5.28% | 5.61% | 2.20% |
Dividend Yield | 2.51% | 2.16% | 1.24% | 1.21% | 1.44% | 1.72% |
Payout Ratio | 44.75% | 28.07% | 30.44% | 18.62% | 26.37% | 32.89% |
Buyback Yield / Dilution | 0.03% | 0.17% | 0.18% | - | - | - |
Total Shareholder Return | 2.54% | 2.33% | 1.43% | 1.21% | 1.44% | 1.72% |